Predictability of 21-Gene Recurrence Score Assay by Using Pathological and Immunohistochemical Parameters in Breast Cancer

BACKGROUND: Oncotype Dx is used to predict the long-term recurrence risk in patients with estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative invasive breast cancer (BC). This study aimed at establishing a correlation between clinicopathological parameters an...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkushi, Abdulmohsen, Omair, Ahmad, Arabi, Haitham, Masuadi, Emad, Abualkhair, Omalkhair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727040/
https://www.ncbi.nlm.nih.gov/pubmed/33343196
http://dx.doi.org/10.1177/1178223420977848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727040/
https://www.ncbi.nlm.nih.gov/pubmed/33343196
http://dx.doi.org/10.1177/1178223420977848

Ejemplares similares